
Kirk A Easley
Articles
-
Nov 13, 2024 |
medrxiv.org | Benjamin Brown |Kirk A Easley |Eric Singer |Samuel J. Hund
Stephen C. Jones and Samuel J. Hund are founding partners and shareholders of CerebroScope. Benjamin R. Brown is a consultant to and shareholder of CerebroScope and Eric L. Singer is a shareholder of CerebroScope. This project was conducted for CerebroScope, a medical device company developing a scalp DC-EEG system for detecting SDs in sABI, concussion, and migraine.
-
Jun 5, 2024 |
nature.com | Ravi M. Patel |Kirk A Easley |Alexandra Towne
Cytomegalovirus (CMV) poses risk of significant morbidity, including sepsis-like syndrome, hepatic dysfunction, and cytopenias [1], in very low birth weight (VLBW, <1500 g) infants. CMV positive breastmilk is an important source of neonatal infection [2]. Despite the high prevalence of CMV in breastmilk, rates of acquired postnatal CMV (pCMV) infection in VLBW infants are low [3].
-
Dec 22, 2023 |
nature.com | Ken Mautner |Paramita Chatterjee |Kirk A Easley |Greg Gibson |Linda Kippner
Correction to: Nature Medicine https://doi.org/10.1038/s41591-023-02632-w, published online 2 November 2023. In the version of the article initially published, Table 1 was missing two rows (“VAS – mean baseline” and “KOOS pain – mean baseline”) that have now been inserted in the HTML and PDF versions of the article.
-
Nov 21, 2023 |
onlinelibrary.wiley.com | Alexandra Forrest |Kirk A Easley |Alicia Smith |Natalie E. Poliektov
DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request.
-
Nov 2, 2023 |
nature.com | Ken Mautner |Paramita Chatterjee |Kirk A Easley |Greg Gibson |Linda Kippner
AbstractVarious types of cellular injection have become a popular and costly treatment option for patients with knee osteoarthritis despite a paucity of literature establishing relative efficacy to each other or corticosteroid injections.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →